#VisualAbstract: Adjuvant capecitabine improves clinical outcomes in patients with locally advanced nasopharyngeal carcinoma
Click to read this study in JAMA Oncology.
Tag: nasopharyngeal
#VisualAbstract: Gemcitabine plus cisplatin improves overall survival compared to fluorouracil plus cisplatin in metastatic or recurrent nasopharyngeal carcinoma
Click to read this study in the Journal of Clinical Oncology.
#VisualAbstract: Camrelizumab plus gemcitabine and cisplatin improves progression-free survival in patients with recurrent or metastatic nasopharyngeal carcinoma
Click to read the study in The Lancet Oncology.
Adjuvant metronomic capecitabine improves survival in patients with locoregionally advanced nasopharyngeal carcinoma
1. Adjuvant capecitabine resulted in fewer instances of disease recurrence and death compared to standard therapy. 2. Overall and failure-free ...
Proton therapy associated with reduced toxicity and equivalent survival outcomes vs radiation therapy amongst patients with nonmetastatic nasopharygneal carcinoma
1. Intensity-modulated proton therapy was associated with fewer adverse events than intensity-modulated radiation therapy in the treatment of patients with ...
#VisualAbstract: Plasma Epstein-Barr virus DNA may have prognostic value for patients with nasopharyngeal carcinoma
Click to read the study in Clinical Cancer Research.
#VisualAbstract: Lobaplatin-based induction chemotherapy is safe and efficacious for patients with advanced nasopharyngeal carcinomas
Click to read the study in The Lancet Oncology.
#VisualAbstract: Endoscopic surgery improves survival compared to radiotherapy in patients with locally recurrent nasopharyngeal carcinoma
Click to read the study in Lancet Oncology.
Conversion of pharyngeal specimens from SARS-nCoV-2-positive to negative may not correlate with end of viral shedding
1. In this study conducted in China, several patients with SARS-CoV-2-negative respiratory samples had sputum and feces that remained positive ...